{"id":10327,"date":"2021-11-23T11:37:15","date_gmt":"2021-11-23T10:37:15","guid":{"rendered":"http:\/\/w332569-www.website.c9x8q4xdx.service.one\/research-publications\/"},"modified":"2024-04-03T09:02:13","modified_gmt":"2024-04-03T07:02:13","slug":"research-publications","status":"publish","type":"page","link":"https:\/\/osloeconomics.no\/en\/research-publications\/","title":{"rendered":"Research publications"},"content":{"rendered":"\n

Health and Life Science<\/h2>\n\n\n\n

Abelsen, B., Pedersen, K., L\u00f8yland, H. I., & Aandahl, E. (2023). Expanding general practice with interprofessional teams: a mixed-methods patient perspective study<\/a>. BMC Health Services Research<\/em>, 23<\/em>(1), 1327.<\/p>\n\n\n\n

Bj\u00f8rk, M. H., Borkenhagen, S., Oteiza, F., Dueland, A. N., S\u00f8rgaard, F. E., S\u00e6ther, E. M., & Bugge, C. (2023). Comparative retention and effectiveness of migraine preventive treatments: A nationwide registry\u2010based cohort study<\/a>. European Journal of Neurology<\/em>.<\/p>\n\n\n\n

Br\u00e5ten, R. H., & Sten-Gahmberg, S. (2022). Unge uf\u00f8re og veien til uf\u00f8retrygd: The path to disability benefits for young people<\/a>. S\u00f8kelys p\u00e5 arbeidslivet<\/em>, 39<\/em>(1), 1-19.<\/p>\n\n\n\n

Br\u00e5ten, R. H., Sten-Gahmberg, S., Bugge, C., Kristiansen I. S., Gardsjord, E. S. & S\u00e6ther, E. M. (2023). \u00d8kt bruk av psykiske diagnoser for unge<\/a>. Tidsskrift for Norsk psykologforening<\/em>.<\/p>\n\n\n\n

Bugge, Christoffer, et al. (2018). Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study<\/a>. BJGP open 2(3<\/em>), bjgpopen18X101596.<\/p>\n\n\n\n

Bugge C, Brustugun OT, S\u00e6ther EM, Kristiansen IS (2021). Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study<\/a>. Medicine<\/em>, 100<\/em>(26), e26523. https:\/\/doi.org\/10.1097\/MD.0000000000026523.<\/p>\n\n\n\n

Bugge, C., Kaasa, S., S\u00e6ther, E. M., Melberg, H. O., & Kristiansen, I. S. (2021). What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study<\/a>. BMJ open<\/em>, 11<\/em>(9), e050564.<\/p>\n\n\n\n

Bugge C, S\u00e6ther EM, Kristiansen IS (2021). Men receive more end-of-life cancer hospital treatment than women: fact or fiction?<\/a>. Acta Oncologica<\/em>. doi: 10.1080\/0284186X.2021.1917000 (Accepted for publication April 2021).<\/p>\n\n\n\n

Bugge C, S\u00e6ther EM, Brustugun OT, Kristiansen IS (2021). Societal cost of cancer in Norway – Results of taking a broader cost perspective<\/a>. Health Policy<\/em>. 2021 May 24;S0168-8510(21)00135-4. doi: 10.1016\/j.healthpol.2021.05.008.<\/p>\n\n\n\n

Engebretsen, I., Munkhaugen, J., Bugge, C., Halvorsen, S., \u00d8degaard, K. M., St\u00f8vring, H., & Kristiansen, I. S. (2022). Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs<\/a>. European Heart Journal Open<\/em>, 2<\/em>(6), oeac070.<\/p>\n\n\n\n

Engebretsen, I., Gilhus, N. E., Kristiansen, I. S., S\u00e6ther, E. M., Lindberg\u2010Schager, I., Arneberg, F., & Bugge, C. (2024). The epidemiology and societal costs of myasthenia gravis in Norway: A non\u2010interventional study using national registry data.<\/a> European Journal of Neurology, e16233.<\/p>\n\n\n\n

Hindhammer, A., Ali, Z., Lange, M., Pedersen, S.H., Steinland, E., S\u00e6ther, E.M., S\u00f8rbr\u00e5ten, T. (2012). Gir innf\u00f8ring av multidose riktigere legemiddelbruk?<\/a> Norsk Farmas\u00f8ytisk tidsskrift 4\/2012<\/em>.<\/p>\n\n\n\n

Hovland R, Bremer S, Frigaard C, Henjum S, Faksv\u00e5g PK, S\u00e6ther EM and Kristiansen IS (2020). Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies<\/a>. International Journal of Pharmacy Practice<\/em>.<\/p>\n\n\n\n

Yngvil Solheim Husum, Ragnhild Haugli Br\u00e5ten, Erik Magnus S\u00e6ther, Morten Carstens Moe, Ivar S\u00f8nb\u00f8 Kristiansen, \u00d8ystein Kalsnes J\u00f8rstad (kommer i 2024). Intravitreal anti-vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study. Acta Ophthalmologica<\/em>.<\/p>\n\n\n\n

I. S. Kristiansen, R. H. Br\u00e5ten, \u00d8. K. J\u00f8rstad, M. C. Moe og E. M. S\u00e6ther (2019). Intravitreal therapy for retinal diseases in Norway 2011\u20132015<\/a>. Acta Ophthalmologica. <\/em>doi: 10.1111\/aos.14262<\/p>\n\n\n\n

Kristiansen IS, Bugge C (2018). Prioritering i pasienters siste leve\u00e5r<\/a>. Tidsskriftet Den Norske Legeforening<\/em>.<\/p>\n\n\n\n

Kristiansen IS, Bugge C, Forde OH (2018). Bidrar overdiagnostikk til h\u00f8ye melanomtall?<\/a> Tidsskriftet Den Norske Legeforening<\/em>.<\/p>\n\n\n\n

L\u00f8yland, H. I., Pedersen, K., Sten-Gahmberg, S., Harsheim, I. G., S\u00e6ther, E. M., Iversen, T., … & Abelsen, B. (2023). Effekter, gevinster og kostnader ved digital hjemmeoppf\u00f8lging \u2013 en samfunns\u00f8konomisk analyse basert p\u00e5 et pragmatisk randomisert fors\u00f8k<\/a>. Magma<\/em>, 26<\/em>(5).<\/p>\n\n\n\n

Oteiza F, L\u00f8yland HI, Bugge C, Kristiansen IS, St\u00f8vring H (2021). Persistence of statin treatment \u2013 the impact of analytic method when estimating drug survival<\/a>. Norsk Epidemiologi 2021; 29<\/em>.<\/p>\n\n\n\n

Pedersen, K., L\u00f8yland, H. I., S\u00e6ther, E. M., Sten-Gahmberg, S., Abelsen, B., Snilsberg, \u00d8., & Iversen, T. (2023). Prim\u00e6rhelseteam \u2013 en mer teambasert fastlegetjeneste<\/a>. Magma<\/em>, 26<\/em>(5).<\/p>\n\n\n\n

Sten-Gahmberg, S., Pedersen, K., Harsheim, I.G. et al. Experiences with telemedicine-based follow-up of chronic conditions: the views of patients and health personnel enrolled in a pragmatic randomized controlled trial.<\/a> BMC Health Serv Res<\/em> 24, 341 (2024). <\/p>\n\n\n\n

Sten-Gahmberg, S., Pedersen, K., Harsheim, I.G. et al.<\/em> Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions<\/a>. Eur J Health Econ<\/em> (2024). <\/p>\n\n\n\n

S\u00e6ther EM, Bugge C, Kristiansen IS (2017). Den nye virkeligheten<\/a>. Overlegen 2-2017:26-7<\/em>.<\/p>\n\n\n\n

S\u00e6ther EM, L\u00f8yland HI, Bugge C (2022). An economic analysis indicates less strict infection control of COVID-19.<\/a> Tidsskriftet Den Norske Legeforening<\/em>.<\/p>\n\n\n\n

Torkki, P., Leskel\u00e4, R. L., Bugge, C., Torfadottir, J. E., & Karjalainen, S. (2022). Cancer-related costs should be allocated in a comparable way\u2014benchmarking costs of cancer in Nordic countries 2012\u20132017<\/a>. Acta Oncologica<\/em>, 61<\/em>(10), 1216-1222.<\/p>\n\n\n\n

You can find more information about our work in health and life sciences on this page<\/a>.<\/p>\n\n\n\n

Competition, Markets and Regulation<\/h2>\n\n\n\n

Asphjell, M. K., Bergh, H. N., Merker, T., & Skaar, J. (2017). Unilateral effects of horizontal mergers with vertical relations between firms and other structural market changes<\/a>. Review of Industrial Organization<\/em>, 51(3), 381-394.<\/p>\n\n\n\n

Bergh, H.N., Gramstad, A.R. & Skaar, J. (2020). Unilateral Price Effects and Vertical Relations Between Merging and Non-merging Firms<\/a>. Review of Industrial Organization<\/em>. 57(1) 131-143.<\/p>\n\n\n\n

Bergh, H. N.; Hammersmark, E. M.; Hansen, J. S.; Skaar, J. (2020). Samfunns\u00f8konomiske konsekvenser av et forbud mot prisdiskriminering i det norske dagligvaremarkedet. Samfunns\u00f8konomen, 136(1), ss. 4-11.<\/p>\n\n\n\n

Braunfels E, Gramstad A, Skaar J (2019). Efficiency Gains vs. Internalization of Rivalry: Brand-Level Evidence from a Merger in the Mobile Telecom Market<\/a>. <\/p>\n\n\n\n

Evensen, C.B., Steen, F., & Ulsaker, S.A. (2023). Co-location, good, bad or both: How do new entries of discount variety stores affect local grocery businesses?<\/a>, Journal of the European Economic Association<\/em><\/p>\n\n\n\n

You can find more information about our work in competition, markets and regulation on this page<\/a>.<\/p>\n\n\n\n

Culture, Sports and Media<\/h2>\n\n\n\n

Skille E\u00c5, Hanstad DV, Svensgaard M, Lien G, Bugge C (2021). Lokale aktivitetsmidler – Implementering av den statlige idrettspolitikken<\/a>. Norsk sosiologisk tidsskrift04 \/ 2021 (Volum 5)<\/em>.<\/p>\n\n\n\n

You can find more information about our work in culture, sports and media on this page<\/a>.<\/p>\n\n\n\n

Resources and Sustainability<\/h2>\n\n\n\n

Arag\u00f3n, F. M., Oteiza, F., & Rud, J. P. (2021). Climate change and agriculture: Subsistence farmers\u2019 response to extreme heat<\/a>. American Economic Journal: Economic Policy<\/em>, 13<\/em>(1), 1-35.<\/p>\n\n\n\n

Arin, P.; & Braunfels, E. (2018). The Resource Curse Revisited: A Bayesian Approach Model Averaging Approach<\/a>. Energy Economics<\/em>, vol. 70(C), pages 170-178. <\/p>\n\n\n\n

You can find more information about our work in resources and sustainability on this page<\/a>.<\/p>\n\n\n\n

Development Economics<\/h2>\n\n\n\n

Abramovsky, L., Augsburg, B., L\u00fchrmann, M., Oteiza, F., & Rud, J. P. (2023). Community matters: Heterogeneous impacts of a sanitation intervention<\/a>. World Development<\/em>, 165<\/em>, 106197.<\/p>\n","protected":false},"excerpt":{"rendered":"

Health and Life Science Abelsen, B., Pedersen, K., L\u00f8yland, H. I., & Aandahl, E. (2023). Expanding general practice with interprofessional […]<\/p>\n","protected":false},"author":4,"featured_media":9864,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-10327","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/pages\/10327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/comments?post=10327"}],"version-history":[{"count":2,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/pages\/10327\/revisions"}],"predecessor-version":[{"id":18755,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/pages\/10327\/revisions\/18755"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/media\/9864"}],"wp:attachment":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/media?parent=10327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}